✨ Thrilled and honored to have been awarded a PhD grant from Danish Diabetes and Endocrine Academy @DDEA_Denmark!
🧠 Thank you this opportunity to help advance the evolving field of #neuroendocrinology!
#fmri#semaglutide
10,5 MILLION DKK TO NEW RESEARCH PROJECTS WITHIN DIABETES AND CLASSICAL ENDOCRINOLOGY 🎉
Read our press release and meet the 14 early-career research talents and two visiting professors who have just secured a grant from DDEA 👇
https://t.co/pYup2FueA0
@novonordiskfond
#NatMetabPicks | Recently published in @NEJM, a group led by @STorekov (@uni_copenhagen) find that combining the GLP1 agonist liraglutide with exercise promotes maintenance of weight loss and improvements in glycemia.
https://t.co/EYmaXMykXb
What is the best way to maintain a weight loss? New exciting RCT from @STorekov proves that liraglutide in combination with #exercise is very effective.
Collab w/ @AmagerHvidovre. Out now in @NEJM.
Read more: https://t.co/i8XWNdFw6e
#weightloss
In this trial, adults with obesity without diabetes were randomly assigned to 1 year of placebo, an exercise program, liraglutide, or exercise plus liraglutide. Combined treatment with exercise and liraglutide improved healthy weight loss maintenance.